Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04878614 · ClinicalTrials.gov registry record · Phase 4
Comparison of Levothyroxine Formulation in Hypothyroid Patients With Enteral Feeding
A Phase 4 study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT04878614 is a Phase 4 study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 3 participants.
The verdict
NCT04878614, a Phase 4 study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to test a liquid levothyroxine formula and examine if it will lead to improvement in management of thyroid function and if it improves hypothyroid symptoms that patients experience.
Interventions
- DRUG Levothyroxine Sodium
- DRUG Levothyroxine Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-05-05 |
| Est. Completion | 2022-02-16 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04878614
The ClinicalTrials.gov registry entry for NCT04878614 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Levothyroxine Sodium is the first listed.
NCT04878614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04878614 about?
NCT04878614 is a clinical study titled "Comparison of Levothyroxine Formulation in Hypothyroid Patients With Enteral Feeding". The purpose of this study is to test a liquid levothyroxine formula and examine if it will lead to improvement in management of thyroid function and if it improves hypothyroid symptoms that patients experience.
What is the current status of trial NCT04878614?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2021-05-05. Estimated completion is 2022-02-16.
What interventions are being tested in trial NCT04878614?
The interventions under investigation include: Levothyroxine Sodium (DRUG), Levothyroxine Tablet (DRUG).
Who is sponsoring clinical trial NCT04878614?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.